![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, April 22, 2015 9:00:28 PM
After listening to the conference call the biggest take away is GW expanding epidiolex in TCS research.. Epidiolex is a pipeline of drugs in just one.. GW is going to continue to use epidiolex to launch new trails to treat even more diseases than just epilepsy.
Looks for profit take for the next few months until data is released again. trading should be similar to what we saw in 2014.. The end of 2015 new highs will be reached pending the final results from the dravet trails. I will be adding to this position during any periods of profit taking. Good luck to all.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM